A randomized, double-blind trial of the effect of treatment with formoterol on clinical and inflammatory parameters of asthma in children

Annals of Allergy, Asthma and Immunology

Volumn 89, Issue 1, 2002, Pages 67-73

  Stelmach, Iwona ^a   Gorski, Pawel ^b   Jerzynska, Joanna ^a   Stelmach, Wlodzimierz ^c   Majak, Pawel ^a   Kuna, Piotr ^b  

^a M Curie Hospital   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c Regional Health Authority   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; EOSINOPHIL CATIONIC PROTEIN; FORMOTEROL; HISTAMINE; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; PLACEBO;

ADOLESCENT; ALLERGIC ASTHMA; ARTICLE; BRONCHUS HYPERREACTIVITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LEUKOCYTE COUNT; LUNG FUNCTION; MALE; MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 19244366069     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61913-8     Document Type: Article

References (34)

1. American Thoracic Society Workshop. Medical Section of The American Lung Association. Immunobiology of asthma and rhinitis. Pathogenic factors and therapeutic options. Am J Respir Crit Care Med 1999;160:1778-1787.
2. Bousquet J, Courigan CJ, Venge P. Peripheral blood markers: evaluation and inflammation in asthma. Eur Respir J 1998; 11 (Suppl):42S-48S.
3. De Blay F, Purohit A, Stenger R, et al. Serum eosinophil cationic protein measurements in the management of perennial and periodic asthma: a prospective study. Eur Respir J 1998; 11:594-598.
4. Ferguson AC, Wong F. Bronchial hyperresponsiveness in asthmatic children: correlation with macrophages and eosinophils in broncholavage fluid. Chest 1989;96:988-991.
5. Ferguson AC, Whitelaw M, Brown H. Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma. J Allergy Clin Immunol 1992;90:609-613.
6. Lai CK, Chan CH, Leung JC, Lai KN. Serum concentration of soluble interleukin 2 receptors in asthma. Correlation with disease activity. Chest 1993;103:782-786.
7. Motojima S, Hirata A, Kushima A, et al. Serum levels of soluble interleukin-2 receptor in asthma patients. J Asthma 1995;32: 151-158.
8. Tsai LC, Tang RB, Hung MW, et al. Expression of serum Il-2, Il-2R, and CD8 levels during hyposensitization in house- dust-sensitive asthmatics. J Asthma 1990;27:307-313.
9. Daher S, Santos LM, Sole D, et al. Interleukin 4 and soluble CD 23 serum levels in asthmatic atopic children. J Invest Allergol Clin Immunol 1995;5:251-254.
10. El Sawy IH, Badr OM, Din EL, et al. Soluble intercellular adhesion molecule-1 in sera of children with bronchial asthma exacerbation. Int Arch Allergy Immunol 1999; 119:126-132.
11. Shiota Y, Wilson JG, Marukana M, et al. Soluble intercellular adhesion molecule 1 (ICAM-1) antigen in sera of bronchial asthmatics. Chest 1996;109:94-99.
12. Kips JC, O'Connor BJ, Inman MD, et al. A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. Am J Respir Crit Care Med 2000;161:996-1001.
13. McIvor RA, Pizzichini E, Turner MO, et al. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med 1998;158:924-930.
14. Spoelstra FM, Postma DS, Hovenga H, et al. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts. Eur Respir J 2000;15:68-74.
15. Van Noord JA, Smeets JJ, Raaijmakers JA, et al. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J 1996;9:1684-1688.
16. Highlights of the Expert Panel Report 2. Guidelines for the diagnosis and management of asthma. Bethesda, MD: NIH Publication no 97-4051A, May 1997.
17. Santanello NC, Barber BL, Reiss TF, et al. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 1997;10:646-651.
18. Crapo RO, Hankinson JL, Irvin C. Standardization of spirometry. Am J Respir Crit Care Med 1995;152:1107-1136.
19. 20. Chest 1983;54:505-506.
20. Postma DS, Lofdahl CG, Tattersfield A, et al. Formoterol used on demand improves quality of life in patients with asthma. Am J Respir Crit Care Med 1999;159:A760.
21. Kemp JP, Cook DA, Incaudo GA, et al. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. J Allergy Clin Immunol 1998;101:188-195.
22. Lipworth B, Tan S, Devlin M, et al. Effects of treatment with formoterol on bronchoprotection against methacholine. Am J Med 1998;104:431-438.
23. Nightingale JA, Rogers DF, Barnes PJ. Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma. Am J Respir Crit Care Med 1999;159: 1786-1790.
24. Greiff L, Wollmer P, Andersson M, et al. Effects of formoterol on histamine induced plasma exudation in induced sputum from normal subjects. Thorax 1998;53:1010-1013.
25. Pedersen B, Faurschou P, Madsen F, et al. Salmeterol treatment reduces the need for inhaled steroids in steroid dependent asthmatics-a randomized, double-blind, placebo-controlled parallel group study. Eur Respir J 1996;9:50S.
26. Lorenzo G, Morici G, Norrito F, et al. Comparison of the effects of salmeterol and salbutamol on clinical activity and eosinophil cationic protein serum levels during the pollen season in atopic asthmatics. Clin Exp Allergy 1995;25:951-956.
27. 2 and TXB2 release in guinea pig eosinophils. Am Rev Respir Dis 1990;141:A29.
28. Pizzichini MM, Kidney JC, Wong BJ, et al. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses. Eur Respir J 1996;9:449-455.
29. Ramage L, Cree IA, Dhillon DP. Comparison of salmeterol with placebo in mild asthma: effect on peripheral blood phagocyte function and cytokine levels. Int Arch Allergy Immunol 1994; 105:181-184.
30. Mohede IC, Van Ark I, Brons FM, et al. Salmeterol inhibits interferon-γ and interleukin-4 production by human peripheral blood mononuclear cells. Int J Immunopharmacol 1996;18: 193-201.
31. Corne JM, Linaker CH, Howarth PH, et al. Effect of systemic β-agonist therapy on IgE production in allergic subjects in vivo. J Allergy Clin Immunol 1998;102:727-731.
32. Ward AJ, Mc Kenniff M, Evans JM, et al. Theophylline: an immunomodulatory role in asthma? Am Rev Respir Dis 1993; 147:518-523.
33. Pauwels R, Van Renterghem D, Van Der Straeten M, et al. The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. J Allergy Clin Immunol 1985;76:583-590.
34. Magnussen H, Reuss G, Jorres R. Theophylline has a dose- related effect on the airway response to inhaled histamine and methacholine in asthmatics. Am Rev Respir Dis 1987;136: 1163-1167.